DOCSLIB.ORG

BUHLMANN Allergen List LA014ML-21EUS

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BUHLMANN Allergen List LA014ML-21EUS BÜHLMANN Allergen List INSECT VENOMS Contrast Media BAG2-I1 HONEY BEE VENOM BAG2-CIOBI IOBITRIDOL BAG2-I1CHK HONEY BEE VENOM CHECK BAG2-CIODI IODIXANOL BAG2-I3 YELLOW JACKET VENOM BAG2-CIOHE IOHEXOL BAG2-I3CHK YELLOW JACKET VENOM CHECK BAG2-CIOME IOMEPROL BAG2-I4 PAPER WASP VENOM BAG2-CIOPA IOPAMIDOL BAG2-I75 EUROPEAN HORNET VENOM BAG2-CIOPR IOPROMIDE Crossreactive Carbohydrate Determinants (CCD) BAG2-CIOXA IOXAGLATE BAG-K202 BROMELAIN BAG2-CIOXI IOXITALAMATE BAG-K225 HRP Antiseptics DRUGS BAG2-CCHX CHLORHEXIDINE Antibiotics Adjuvants BAG2-C1 PENICILLIN G BAG2-CE466 CARBOXYMETHYLCELLULOSE BAG2-C11 BENZYLPENICILLOYL-POLYLYSIN, PPL BAG2-CPEG PEG-4000 BAG2-C12 BENZYLPENICILLIN +-ACID, MDM Proton Pump Inhibitors (PPI) BAG2-C2 PENICILLIN V BAG2-COME OMEPRAZOLE BAG2-C3 CEPHALOSPORIN C BAG2-CESO ESOMEPRAZOLE BAG2-C31 CEFAMANDOLE BAG2-CPANT PANTOPRAZOLE BAG2-C32 CEFAZOLIN BAG2-CLAN LANSOPRAZOLE BAG2-C33 CEFUROXIME Beta Blockers BAG2-C34 CEFACLOR BAG2-CBIS BISOPROLOL BAG2-C35 CEFTRIAXONE BAG2-CMET METOPROLOL new BAG2-C36 LEVOFLOXACIN ACE inhibitors BAG2-C61 SULFAMETHOXAZOLE BAG2-CRAM RAMIPRIL BAG2-C62 TRIMETHOPRIM ENVIRONMENTAL & OCCUPATIONAL BAG2-C75 TETRACYCLINE BAG-K79 PHTALIC ANHYDRIDE / PHTALIC ACID BAG2-C76 DOXYCYCLINE BAG-K82 LATEX BAG2-C81 CIPROFLOXACINE BAG-K85 CHLORAMINE-T BAG2-C82 MOXIFLOXACINE BAG-K87 ALPHA-AMYLASE BAG2-C203 AMPICILLINE BAG2-C204 AMOXICILLINE INHALANTS BAG2-CCLA CLARITHROMYCINE Grasses CLAVULANIC ACID AMOX (CLAVULANIC BAG2-CCLAX BAG-G2 BERMUDA GRASS ACID AMOXICILLINE 20/80) BAG-G3 ORCHARD GRASS BAG2-CCLIN CLINDAMYCINE BAG-G5 PERENNIAL RYE GRASS BAG2-CERY ERYTHROMYCINE BAG-G6 TIMOTHY GRASS BAG2-CRIF RIFAMPICINE BAG-G12 CULTIVATED RYE GRASS Analgesics BAG-GX1 6-GRASS MIX BAG2-C51 LYS-ASPIRIN (G3, G5, G6, MEADOW FESCUE, MEADOW BAG2-C52 DICLOFENAC GRASS, VELVET GRASS) BAG2-C53 IBUPROFEN Weeds BAG2-C54 INDOMETHACIN BAG-W1 COMMON RAGWEED BAG2-C55 ACETAMINOPHEN BAG-W6 MUGWORT BAG2-C56 MEFENAMIC ACID BAG-W9 RIBWORT/PLANTAIN BAG2-C57 PHENYLBUTAZONE BAG-W19 PELLITORY BAG2-C58 PROPYPHENAZONE BAG-WX1 RAGWEED MIX BAG2-C59 DIPYRONE / METAMIZOLE (W1, GIANT RAGWEED) BAG2-CNAP NAPROXEN Trees BAG2-CTRA TRAMADOL new BAG-T3 COMMON BIRCH BAG2-C114 SALICYLIC ACID (SODIUM SALT) BAG-T4 HAZEL Myorelaxants BAG-T7 OAK BAG2-CATR ATRACURIUM BAG-T9 OLIVE BAG2-CCAT CISATRACURIUM Molds BAG2-CMIV MIVACURIUM BAG-M1 PENICILLIUM BAG2-CPAN PANCURONIUM BAG-M2 CLADOSPORIUM BAG2-CPRO PROPOFOL BAG-M3 ASPERGILLUS BAG2-CROC ROCURONIUM BAG-M5 CANDIDA ALBICANS BAG2-CSUX SUXAMETHONIUM BAG-M6 ALTERNARIA BAG2-CVEC VECURONIUM BAG2-CNBX NEUROMUSCULAR BLOCKERS MIX (CATR, CCAT, CMIV, CPAN, CPRO, CROC, CSUX, CVEC) Local Anesthetics BAG2-CART ARTICAINE BAG2-CBUP BUPIVACAINE BAG2-CMEP MEPIVACAINE BAG2-CLID LIDOCAINE LA014ML-21 EUS Allergens/Allergen Mixes Mites, Animals & Insects BAG-F14 SOYBEAN BAG-D1 HOUSE DUST MITE BAG-F17 HAZELNUT BAG-D2 AMERICAN HOUSE DUST MITE BAG-F20 ALMOND BAG-D70 ACARUS SIRO BAG-F202 CASHEW NUT BAG-DX1 STORAGE MITE MIX BAG-F203 PISTACHIO NUT (D70, LEPIDOGLYPHUS DESTRUCTOR, BAG-F256 WALNUT TYROPHAGUS PUTRESCENTIA, GLYCY- Cereales PHAGUS DOMESTICUS) BAG-F4 WHEAT BAG-E1 CAT EPITHELIUM BAG2-TRIA12 rTRI A 12, Wheat Profilin* BAG2-FELD1 rFEL D 1, CAT* BAG-F79 GLUTEN - Wheat BAG-E2 DOG EPITHELIUM GLIADIN - Wheat CULICOIDES ANTIGEN (HORSE APPLICA- BAG-F98 BAG2-CUL TON) RUO BAG-F5 RYE FLOUR BAG-IX1 INHALANT MIX BAG-F6 BARLEY FLOUR (GX1, G12, T3, T4, W6, W9, M6, D1, D2, BAG-F7 OAT FLOUR E1, E2) BAG-F8 MAIZE FOOD BAG2-ZEAM12 rZEA M 12, Maize Profilin* Egg BAG-F81 MAIZE STARCH BAG-F1 EGG WHITE BAG-F9 RICE BAG-F75 EGG YOLK BAG-F45 BAKER`s YEAST Milk BAG-FX1 FOOD MIX BAG-F2 COW MILK (F1, F75, F2, F3, F4, F13, F14, F17, BAG-F76 ALPHA-LACTALBUMIN F24) BAG-F77 BETA-LACTOGLOBULIN FOOD ADDITIVES BAG-F78 CASEIN BAG2-C103 TARTRAZINE Fish & Meat BAG2-C105 METHYLENE BLUE BAG-F3 CODFISH BAG2-C111 SODIUM-BENZOATE BAG-F23 CRAB (CALLINECTES SAPIDUS) BAG2-C112 SODIUM-NITRITE BAG-F24 SHRIMP BAG2-C113 POTASSIUM-METABISULFITE BAG-F258 SQUID BAG2-C114 SODIUM-SALICYLATE BAG-F290 OYSTER BAG2-CE104 QUINOLINE YELLOW BAG-P4 ANISAKIS BAG2-CE110 SUNSET YELLOW FCF BAG-F26 PORK BAG2-CE122 CHROMOTROPE FB BAG-F27 BEEF BAG2-CE123 AMARANTH Fruits & Vegetables BAG2-CE124 NEW COCCINE BAG-F25 TOMATO BAG2-CE127 ERYTHROSINE BAG-F31 CARROT BAG2-CE131 PATENT BLUE V BAG-F33 ORANGE BAG2-CE132 INDIGO CARMINE BAG-F85 CELERY BAG2-CE151 BRILLIANT BLACK BN BAG-F95 PEACH BAG2-CE202 SORBIC ACID BAG2-PRUP3 nPRU P 3 LTP PEACH BAG2-CE621 GLUTAMATE BAG2-MALD1 rMAL D 1, APPLE* BAG2-C101 FOOD COLORANTS I MIX Seeds, Beans & Nuts (CE104, CE110, CE122, CE123, CE124) BAG-F10 SESAME BAG2-C102 FOOD COLORANTS II MIX BAG-F13 PEANUT (CE127, CE131, CE132, CE151) BAG2-ARAH1 nARA H 1 PEANUT BAG2-ARAH2 nARA H 2 PEANUT BAG2-ARAH6 nARA H 6 PEANUT *recombinant allergen Resuspend allergens with 250 µl Stimulation Buffer (STB) Up to 4 stimulations per allergen vial Store unopened allergens at -20 °C until exp. date Use a fresh allergen vial each time a new stimulation is performed; except Bee & Wasp allergens: Reconstituted Bee & Wasp allergens (BAG2-I1 & BAG2-I3) are stable for 1 month stored at -20°C For further information refer to www.buhlmannlabs.com. Flow CAST® (FK-CCR-U), Ordering Code: CAST® ELISA (EK-CAST-U/EK- Flow CAST® FK-CCR-U 100 tests CAST5-U) and CAST® allergens CAST® ELISA EK-CAST-U 192 wells are available For Research Use EK-CAST5-U 480 wells BÜHLMANN Laboratories AG BUHLMANN Diagnostics Corp Only in the US and Canada. CAST® is a registered trademark of BÜHLMANN Switzerland USA / Canada Not for use in diagnostic proce- in many countries. [email protected] [email protected] dures. www.buhlmannlabs.ch www.buhlmannlabs.com Phone +41 61 487 12 12 Phone 844 300 9799.
Load more

Recommended publications
  • Dental Management of Patients with Inherited Bleeding Disorders: a Multidisciplinary Approach
    Dental management of patients with inherited bleeding disorders: a multidisciplinary approach Hassan Abed, BDS, MSc ¢ Abdalrahman Ainousa, BDS, MSc Bleeding disorders can be inherited or acquired and leeding disorders can result from inherited genetic demonstrate different levels of severity. Dentists may be defects or be acquired due to use of anticoagulant med- called on to treat patients who have bleeding disor- ications or medical conditions such as liver dysfunc- ders such as hemophilia A and von Willebrand disease B 1-3 tion, chronic kidney disease, and autoimmune disease. During (vWD). Dental extraction in any patient with clotting blood vessel injury, hemostasis relies on interactions between factor defects can result in a delayed bleeding episode. the vascular vessel wall and activated platelets as well as clot- 4 Local hemostatic measures provide effective results in ting factors. Any marked defect at one of these stages results a majority of cases but are insufficient in patients with in bleeding disorders. Vascular wall defects, platelet defects, severe hemophilia A and vWD. Therefore, consultation or deficiency of clotting factors can affect the severity level of 5 with the patient’s hematologist is required to ensure bleeding episodes. Thus, patients may have mild, moderate, or preoperative prophylactic coverage. Dental care provid- severe episodes of bleeding. ers have to be aware of any signs of bleeding disorders and refer patients for further medical investigations. This Sources of inherited bleeding disorders article aims to provide dental care providers with the Vascular wall defects knowledge to manage patients with inherited bleeding A patient’s bleeding disorder may be unrecognized, and bleeding disorders, especially hemophilia A and vWD.
    [Show full text]
  • Mepivacaine Hydrochloride Injection
    POLOCAINE- mepivacaine hydrochloride injection, solution Dentsply Pharmaceutical ---------- 3% Polocaine® DENTAL Mepivacaine Hydrochloride 3% (30 mg/mL) (Mepivacaine Hydrochloride Injection, USP) 2% Polocaine® DENTAL with Levonordefrin 1:20,000 Mepivacaine Hydrochloride 2% (20 mg/mL) with Levonordefrin 1:20,000 (Mepivacaine Hydrochloride and Levonordefrin Injection, USP) Rx Only THESE SOLUTIONS ARE INTENDED FOR DENTAL USE ONLY. DESCRIPTION Mepivacaine Hydrochloride, a tertiary amine used as a local anesthetic, is 1-methyl-2,' 6' - pipecoloxylidide monohydrochloride with the following structural formula: It is a white, crystalline, odorless powder soluble in water, but very resistant to both acid and alkaline hydrolysis. Levonordefrin, a sympathomimetic amine used as a vasoconstrictor in local anesthetic solution, is (-)-α-(1-Aminoethyl)-3, 4-dihydroxybenzyl alcohol with the following structural formula: It is a white or buff-colored crystalline solid, freely soluble in aqueous solutions of mineral acids, but practically insoluble in water. DENTAL CARTRIDGES MAY NOT BE AUTOCLAVED. 3% (30 mg/mL) Polocaine® DENTAL (mepivacaine hydrochloride injection 3% (30 mg/mL)) and 2% (20 mg/mL) Polocaine® DENTAL with Levonordefrin 1:20,000 (mepivacaine hydrochloride 2% (20 mg/mL) with levonordefrin 1:20,000 injection) are sterile solutions for injection. sterile solutions for injection. COMPOSITION: CARTRIDGE Each mL contains: 2% 3% Mepivacaine Hydrochloride 20 mg 30 mg Levonordefrin 0.05 mg - Sodium Chloride 4 mg 6 mg Potassium metabisulfite 1.2 mg - Edetate disodium 0.25 mg - Sodium Hydroxide q.s. ad pH; Hydrochloric 0.5 mg - Acid Water For Injection, qs. ad. 1 mL 1 mL The pH of the 2% cartridge solution is adjusted between 3.3 and 5.5 with NaOH.
    [Show full text]
  • 4% Citanest® Plain Dental (Prilocaine Hydrochloride Injection, USP) for Local Anesthesia in Dentistry
    4% Citanest® Plain Dental (Prilocaine Hydrochloride Injection, USP) For Local Anesthesia in Dentistry Rx only DESCRIPTION 4% Citanest Plain Dental (prilocaine HCI Injection, USP), is a sterile, non-pyrogenic isotonic solution that contains a local anesthetic agent and is administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The quantitative composition is shown in Table 1. 4% Citanest Plain Dental contains prilocaine HCl, which is chemically designated as propanamide, N-(2- methyl-phenyl) -2- (propylamino)-, monohydrochloride and has the following structural formula: Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. The specific quantitative composition is shown in Table 1. TABLE 1. COMPOSITION Product Identification Formula (mg/mL) Prilocaine HCl pH 4% Citanest® Plain Dental 40.0 6.0 to 7.0 Note: Sodium hydroxide or hydrochloric acid may be used to adjust the pH of 4% Citanest Plain Dental Injection. CLINICAL PHARMACOLOGY Mechanism of Action: Prilocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. Onset and Duration of Action: When used for infiltration injection in dental patients, the time of onset of anesthesia averages less than 2 minutes with an average duration of soft tissue anesthesia of approximately 2 hours. Based on electrical stimulation studies, 4% Citanest Plain Dental Injection provides a duration of pulpal anesthesia of approximately 10 minutes in maxillary infiltration injections. In clinical studies, this has been found to provide complete anesthesia for procedures lasting an average of 20 minutes. When used for inferior alveolar nerve block, the time of onset of 4% Citanest Plain Dental Injection averages less than three minutes with an average duration of soft tissue anesthesia of approximately 2 ½hours.
    [Show full text]
  • Local Anesthetic Half Life (In Hours) Lidocaine 1.6 Mepivacaine 1.9 Bupivacaine 353.5 Prilocaine 1.6 Articaine 0.5
    Local Anesthetics • The first local anesthetics History were cocaine and procaine (Novacain) developed in ltlate 1800’s • They were called “esters” because of their chemical composition • Esters had a slow onset and short half life so they did not last long History • Derivatives of esters called “amides” were developed in the 1930’s • Amides had a faster onset and a longer half life so they lasted longer • AidAmides quiklickly repldlaced esters • In dentistry today, esters are only found in topical anesthetics Generic Local Anesthetics • There are five amide anesthetics used in dentistry today. Their generic names are; – lidocaine – mepivocaine – bupivacaine – prilocaine – artica ine • Each is known by at least one brand name Brand Names • lidocaine : Xylocaine, Lignospan, Alphacaine, Octocaine • mepivocaine: Carbocaine, Arestocaine, Isocaine, Polocaine, Scandonest • prilocaine : Citanest, Citanest Forte • bibupivaca ine: MiMarcaine • articaine: Septocaine, Zorcaine About Local Anesthetic (LA) • Local anesthetic (LA) works by binding with sodium channels in neurons preventing depolarization • LA is inactivated at the injection site when it is absorbed into the blood stream and redistributed throughout the body • If enough LA is absorbed, sodium channels in other parts of the body will be blocked, causing systemic side effects About LA • A clinical effect of LAs is dilation blood vessels, speeding up absorption and distribution • To counteract this dilation so anesthesia is prolonged, , a vasoconstrictor is often added to LAs • However, vasoconstrictors have side effects also Metabolism and Excretion • Most amide LAs are metabolized (inactivated) by the liver and excreted by the kidneys. • Prilocaine is partially metabolized by the lungs • Articaine is partially metabolized by enzymes in the bloo d as well as the liver.
    [Show full text]
  • Efficacy of 2% Lidocaine and 4% Articaine in Mandibular Molars with Different Pulp Diagnoses in the Mandibular Technique1
    Efficacy of 2% lidocaine and 4% articaine in mandibular molars with different pulp diagnoses in the mandibular technique1 Eficacia de la lidocaína al 2% y la articaína al 4% en molares mandibulares con diferentes diagnósticos pulpares en la técnica mandibular1 Adel Martínez Martínez2, Evelyn Freyle Granados3, Natalia Senior Carmona3 1 Paper submitted in partial fulfillment of the requirements for the degree of Endodontist 2 Assistant Professor, GITOUC Group, School of Dentistry, Universidad de Cartagena 3 DDS, Specialist in Endodontics, Postgraduate program in Endodontics, School of Dentistry, Universidad de Cartagena ABSTRACT Introduction: the inferior alveolar dental nerve block is the method most commonly used by endodontists to achieve local anesthesia during treatments. This study compared the efficacy of two anesthetic solutions: 2% lidocaine with 1:80,000 epinephrine and 4% articaine with 1:100,000 epinephrine in patients with different ARTICLES ORIGINAL pulp diagnoses requiring endodontic treatment. Method: an interventional, randomized clinical trial. The sample included 36 patients who were treated at the postgraduate endodontics service at the Universidad de Cartagena in the year 2016. Descriptive statistics and the Chi2 test were used for data analysis, using a limit of 0.05. Results: articaine showed a greater anesthetic effect in vestibular mucosa (88.9%) and tip of tongue (55.6%), compared with lidocaine. The rates of anesthetic success in the lidocaine and articaine groups were 5.6% and 22.2% respectively, but this difference was not statistically significant (p = 0.633). In teeth with normal pulp, the efficacy was 27.3%, and this value considerably decreased in teeth with asymptomatic and symptomatic irreversible pulpitis, with percentages of 5.8% and 12.5% respectively, although this difference was not statistically significant (p = 0.276).
    [Show full text]
  • Comparative Evaluation of Lignocaine, Articaine and Ropivacaine for Proximal Paravertebral Anaesthesia in Cattle S.D
    International Journal of Science, Environment ISSN 2278-3687 (O) and Technology, Vol. 8, No 3, 2019, 674 – 679 2277-663X (P) COMPARATIVE EVALUATION OF LIGNOCAINE, ARTICAINE AND ROPIVACAINE FOR PROXIMAL PARAVERTEBRAL ANAESTHESIA IN CATTLE S.D. Chepte1, M.G. Thorat2*, S.P. Waghmare3, M.V. Ingawale4, S.P. Mehesare5 M.V. Joshi5 and F.A. Fani6 1PhD Scholar, 2Professor and Head, 3Hospital Superintendent, 4Assistant Professor and 5Rtd Professor and 6Hospital Registrar Department of Surgery and Radiology Post Graduate Institute of Veterinary and Animal Sciences, MAFSU Akola (M.S.) E-mail: [email protected] (*Corresponding Author) Abstract: Present study was conducted on 18 clinical case of cattle presented with various gastro-intestinal affections to TVCC, PGIVAS, Akola subjected for laparotomy surgical procedure. All clinical cases were randomly divided into three equal group (n=6) and proximal paravertebral nerve block was performed by using Lignocaine, Articaine and Ropivacaine. Comparative anaesthetic assessment of onset of action and duration of anaesthesia along with clinicophysiological parameters were evaluated. Keywords: Lignocaine, Articaine, Ropivacaine, Cattle, Paravertebral. INTRODUCTION Thoracolumbar paravertebral block is performed to anesthetize the surgical site for a flank laparotomy. This technique is preferable to infiltration anesthetic techniques because of the smaller volume of anesthetic agent required, production of a more extensive anesthesia of the abdominal wall and reduced postoperative swelling and hematoma (Rostami & Vesal 2011). In ruminants, flank region is the most common site for laparotomy; caesarian section, rumenotomy, intestinal obstruction, volvulus, ruminal fistula, foreign body syndrome and hernia etc. (Lee, 2006; Kumar, 2003). Paravertebral nerve block results effective analgesia in all layers of the abdominal wall while the tissue infiltration, inverted L block may not produce analgesia of all muscle layers as well as peritoneum specially in fat animals (Sloss and Dufty, 1977).
    [Show full text]
  • Meta-Xylene: Identification of a New Antigenic Entity in Hypersensitivity
    Clinical Communications Meta-xylene: identification of a new Our patient is a 53-year-old male who presented in 2003 with antigenic entity in hypersensitivity contact dermatitis after the use of lidocaine and disinfection with reactions to local anesthetics chlorhexidine. In 2006, an extensive skin testing by patch, prick, Kuntheavy Ing Lorenzini, PhDa, intradermal sampling, and graded challenge was performed as b c followed. The patch tests were performed with the thin layer Fabienne Gay-Crosier Chabry, MD , Claude Piguet, PhD , rapid use epicutaneous test, using the caine mix (benzocaine, a and Jules Desmeules, MD tetracaine, and cinchocaine), the paraben mix (methyl, ethyl, propyl, butyl, and benzylparaben), and the Balsam of Peru. The Clinical Implications caine and paraben mix were positive, and the patch test was possibly positive for Balsam of Peru. The prick test performed The authors report a patient who presented delayed with preservative-free lidocaine 20 mg/mL (Lidocaïne HCl hypersensitivity reactions to several local anesthetics, all “Bichsel” 2%, Grosse Apotheke Dr. G. Bichsel, Switzerland) was containing a meta-xylene entity, but not to articaine, negative. The intradermal test, performed with lidocaine 20 mg/ which is a thiophene derivative. Meta-xylene could be the mL containing methylparaben (Xylocain 2%, AstraZeneca, immunogenic epitope. Switzerland) with 1/10 and 1/100 dilutions, was negative. The subcutaneous challenge test was performed with 10 mg of preservative-free lidocaine 20 mg/mL (Lidocaïne HCl “Bichsel” TO THE EDITOR: 2%, Grosse Apotheke Dr. G. Bichsel) and lidocaine 20 mg/mL containing methylparaben (Lidocaïne Streuli 2%, Streuli, Hypersensitivity reactions to local anesthetics (LAs) are rare and Switzerland), both of which were positive and had the appear- represent less than 1% of all adverse reactions to LAs.
    [Show full text]
  • Local Anesthetics
    Local Anesthetics Introduction and History Cocaine is a naturally occurring compound indigenous to the Andes Mountains, West Indies, and Java. It was the first anesthetic to be discovered and is the only naturally occurring local anesthetic; all others are synthetically derived. Cocaine was introduced into Europe in the 1800s following its isolation from coca beans. Sigmund Freud, the noted Austrian psychoanalyst, used cocaine on his patients and became addicted through self-experimentation. In the latter half of the 1800s, interest in the drug became widespread, and many of cocaine's pharmacologic actions and adverse effects were elucidated during this time. In the 1880s, Koller introduced cocaine to the field of ophthalmology, and Hall introduced it to dentistry Overwiev Local anesthetics (LAs) are drugs that block the sensation of pain in the region where they are administered. LAs act by reversibly blocking the sodium channels of nerve fibers, thereby inhibiting the conduction of nerve impulses. Nerve fibers which carry pain sensation have the smallest diameter and are the first to be blocked by LAs. Loss of motor function and sensation of touch and pressure follow, depending on the duration of action and dose of the LA used. LAs can be infiltrated into skin/subcutaneous tissues to achieve local anesthesia or into the epidural/subarachnoid space to achieve regional anesthesia (e.g., spinal anesthesia, epidural anesthesia, etc.). Some LAs (lidocaine, prilocaine, tetracaine) are effective on topical application and are used before minor invasive procedures (venipuncture, bladder catheterization, endoscopy/laryngoscopy). LAs are divided into two groups based on their chemical structure. The amide group (lidocaine, prilocaine, mepivacaine, etc.) is safer and, hence, more commonly used in clinical practice.
    [Show full text]
  • Local Anesthetic
    Sedation & Anesthesia in Dental Practice LOCAL ANESTHESIA: “30+ Years of Hits, Misses and Near MiSs- THE NATIONAL NETWORK for ORAL HEALTH ACCESS es” THE 2015 ANNUAL CONFERENCE Indianapolis, Indiana November 16th , 2015 Mel Hawkins, DDS, BScD AN Dentist / Dentist Anesthesiologist Toronto, ON Canada www.sedationdentistry.us [email protected] AGENDA 1 2 3 Anatomy, What can What’s new? Blocks, go wrong Paresthesia, Road and what reversing, Blocks, to do buffering, inhalational More about it? and more Blocks PART ANATOMY, BLOCKS, ROAD BLOCKS AND MORE BLOCKS THE ELUSIVE McDibular BLOCK …millions and millions served . Trivia: The dental local anesthesia industry combined now serves up 330 million cartridges every year in North America A=86% B=7% C=7% Inferior Alveolar Block “Conventional” as opposed to a “mandibular block” Relationship of: Conventional (inferior alveolar) Akinosi, closed mouth Gow-Gates “condylar neck” Hybrid, “mix and match” blocks Reasons for Failure Anatomical Variations: • Hard tissue anatomy • Connective tissue and Neurovascular anatomy Dr. George Gow-Gates, Dr. J. Watson, University of Sydney, Australia 3 Major Factors: •Internal Oblique Ridge •Sphenomandibular fascial barrier •Risks: Nerves, Arteries The distance between the internal and external oblique line of the mandible varies. Adapted from Dr. N. B. Jorgensen Netter, Grant’s Anatomy Anatomical Influences: The maxillary artery, passes through the high pterygomandibular triangle region The Question is: What is the risk of an intraarterial injection? Clinically Unlikely Internal Maxillary Artery Characteristics: • Thick smooth muscle wall • Well innervated • Constricts or arteriospasms, eliminates lumen • Artery is mobile within the anatomical area • Pulse pressure True Confessions Histology Horizontal X-S, level of Conventional I.A.N.Block Courtesy Dr.
    [Show full text]
  • Comparison of Articaine and Prilocaine Anestiesia by Infiltration in Maxillary and Mandibular Archles Daniel A
    Anesth Prog 37:230-237 1990 SCIENTIFIC REPORTS Comparison of Articaine and Prilocaine Anestiesia by Infiltration in Maxillary and Mandibular Archles Daniel A. Haas, DDS, PhD, David G. Harper, DDS, Michael A. Saso, DDS, and Earle R. Young, DDS, MSc Department of Anaesthesia, Faculty of Dentistry, University of Toronto Claims that labial infiltration of the local anesthetic It is commonly accepted that in order to achieve local articaine HCl (Ultracaine DS"M) results in anesthesia for procedures on teeth or buccal soft tissue anesthesia of mandibular pulpal as well as in the maxillary arch, administration of local anesthetics maxillary and mandibular lingual soft tissue have by buccal infiltration, also known as a paraperiosteal field never been scientifically substantiated. The aim of block, is routinely successful. Palatal soft tissue anesthesia this investigation was to evaluate these claims, by requires a separate palatal injection, a technique that is comparing articaine to a standard anesthetic, often painful for the patient. Any local anesthetic that prilocaine HCI (Citanest ForteTM). To investigate would permit use of buccal infiltration to gain palatal anes- this, a double blind, randomized study was thesia would be of great advantage in dentistry. For proce- conducted in healthy adult volunteers. In each dures in the mandibular arch, in adults, the thickness of volunteer, the ability to induce maxillary and buccal cortical bone precludes buccal infiltration ap- mandibular anesthesia following labial infiltration proaches producing pulpal or lingual soft tissue anesthe- with articaine was compared to prilocaine given sia, necessitating administration of local anesthetic by contralaterally. Anesthesia was determined by nerve block techniques.
    [Show full text]
  • Articaine and Lidocaine: How Their Chemical Properties Can Impact
    LOCAL ANESTHESIA IN DENTISTRY Clinical tips Articaine and Lidocaine: how their chemical properties can impact your clinical use Introduction Key items Local anesthetics such as lidocaine and • Reinjection articaine are the most commonly • Drug potency administered medications in dentistry. • Onset of action • Duration of anesthetic effect To appreciate the differences in these • Toxicity agents the chemical properties that • Use in patients younger than 4 differentiate them is important. years old • Use in geriatric patients The chemistry and pharmacology of a local • Complications anesthetic can give valuable information about which clinical effect you can expect Reinjection & Elimination half-life when you use them. The half-life of a drug is the amount of time that it will take the plasma concentration of a drug to be halved. Articaine contains an Articaine additional ester group that is quickly (and mostly) hydrolyzed by plasma esterases. This gives articaine an elimination half-life of approximately 20 minutes. The half-life of lidocaine is approximately 90 minutes. Thiophene ring Lidocaine is mostly hydrolyzed in the liver. The enzymes in the liver act slower than plasma enzymes. This makes reinjection of articaine safer, since the majority of the initial dose is metabolized after approximately half an hour, and the reinjected dose will not be added to the initial dose.1 Lidocaine Local Articaine Lidocaine anesthetic Elimination 20 minutes 90 minutes half-time Benzene ring Page 1 LOCAL ANESTHESIA IN DENTISTRY Clinical tips Drug potency & Lipid solubility protein bound agents are not reabsorbed into the central circulation as quickly and Lipid solubility affects the anesthetic therefore may have a lesser tendency potency.
    [Show full text]
  • Prescribing Information Carbocaine 1%
    Prescribing Information Carbocaine 1% 10 mg/mL, Mepivacaine Hydrochloride Injection, USP Carbocaine 2% 20 mg/mL, Mepivacaine Hydrochloride Injection, USP Local Anesthetic Pfizer Canada Inc. DATE OF REVISION: 17300 Trans-Canada Highway August 2, 2017 Kirkland, Québec NTF: February 14, 2018 H9J 2M5 Control Number: (204807) 1 Prescribing Information Carbocaine 1% 10 mg/mL, Mepivacaine Hydrochloride Injection, USP Carbocaine 2% 20 mg/mL, Mepivacaine Hydrochloride Injection, USP Local Anesthetic Pharmacology: Mepivacaine stabilizes the neuronal membrane and prevents the initiation and transmission of nerve impulses, thereby effecting local anesthesia. Its pharmacological properties are somewhat similar to those of lidocaine, which it resembles chemically. Its action is more rapid in onset and somewhat more prolonged than that of lidocaine. It has been employed for all types of infiltration and regional nerve block anesthesia. Onset of anesthesia is rapid, the time of onset for sensory block ranging from about 3 to 20 minutes depending upon such factors as the anesthetic technique, the type of block, the concentration of the solution and the individual patient. The degree of motor blockade produced is dependent on the concentration of the solution. The 1% concentration will block sensory and sympathetic conduction without loss of motor function and will be effective in small superficial nerve blocks. The 2% concentration of mepivacaine will produce complete sensory and motor block of any nerve group. The duration of anesthesia also varies depending upon the technique and type of block, the concentration and the individual. Mepivacaine will normally provide anesthesia which is adequate for 2 to 2½ hours of surgery. It has been reported that vasoconstrictors do not significantly prolong anesthesia with mepivacaine, but epinephrine (1:200 000) may be added to the mepivacaine solution to promote local hemostasis and to delay systemic absorption of the anesthetic.
    [Show full text]